The India animal vaccine market size was USD 467.41 Million in 2024 and is expected to grow to USD 852.11 Million by 2033. The market is forecasted to expand at a CAGR of 6.90% during the period 2025-2033. Growth is fueled by a rising livestock population, government vaccination programs, increasing awareness of animal health, and rising demand for dairy and meat products, supported by technological advancements and investments in veterinary healthcare. the report offers a comprehensive analysis of the industry, including India animal vaccine market share, and regional insights.

Sample Request Link: https://www.imarcgroup.com/india-animal-vaccine-market/requestsample

MARKET TRENDS

India's vast livestock population, encompassing poultry, cattle, sheep, and goats, significantly contributes to the agrarian economy through milk, meat, eggs, and agricultural labor. Preventing disease outbreaks and maintaining productivity requires regular vaccination by farmers and livestock producers. The growing demand for dairy and meat products prioritizes animal health, driving increased vaccine use and veterinary services investments, especially in rural and semi-urban areas, which fuels market expansion.

In November 2024, Boehringer Ingelheim introduced a next-generation poultry vaccine targeting Marek’s disease. This innovative vaccine, recommended for in-ovo vaccination of embryonated eggs and day-old chicks, offers enhanced safety and efficacy against virulent strains. This development is pivotal for poultry farmers to reduce outbreaks, improve flock health, and secure food supply amidst rising demand for quality poultry products.

MARKET GROWTH FACTORS

Growth is driven by the escalating livestock population and the vital role it plays in India’s agrarian economy. With extensive populations in poultry, cattle, sheep, and goats, the sector generates essential outputs such as milk, meat, and eggs while supporting agriculture labor. The necessity for regular vaccinations to prevent disease outbreaks and ensure productivity underpins sustained market growth.

Government initiatives significantly propel growth. For instance, the NADCP focuses on eradicating diseases such as FMD and Brucellosis that impact livestock productivity and farmer income. These programs enhance vaccine accessibility through subsidized distribution and campaigns, particularly in rural areas, positively impacting market forecasts. Additionally, government collaborations with private firms expedite advanced vaccine development.

Explore the Full Report with Charts, Table of Contents, and List of Figures: https://www.imarcgroup.com/india-animal-vaccine-market